Biosketch / Results /

Richard Nachtigall

Clinical Professor, Department of Medicine
Medicine

Contact Info

212/355-7667

Education

1958-1959 — Beth Israel Medical Center (Medicine), Residency Training
1959-1961 — NYU Medical Center (Medicine), Residency Training

Is Percentile Body Fat by Dual-Energy X-Ray Absorptiometry a Better Surrogate for Metabolic Health Than Body Mass Index?
Goldstein, Steven Robert; Nachtigall, Lila E; Nachtigall, Richard. Is Percentile Body Fat by Dual-Energy X-Ray Absorptiometry a Better Surrogate for Metabolic Health Than Body Mass Index? [Meeting Abstract]. Obstetrics & gynecology. 2015 MAY;125:98S-99S (1610192)

Osteoporosis Risk Factors and Early Life-style Modifications to Decrease Disease Burden in Women
Nachtigall, Margaret J; Nazem, Taraneh G; Nachtigall, Richard H; Goldstein, Steven R. Osteoporosis Risk Factors and Early Life-style Modifications to Decrease Disease Burden in Women. Clinical obstetrics & gynecology. 2013 Dec;56(4):650-653 (614322)

A prospective study of DT56a (Femarelle) for the treatment of postmenopausal vaginal atrophy
Nachtigall, M; Naftolin, F; Nachtigall, R; Yoles, I; Nachtigall, L E. A prospective study of DT56a (Femarelle) for the treatment of postmenopausal vaginal atrophy [Meeting Abstract]. Menopause. 2011 December;18(12):1365-1365 (166537)

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women
Nachtigall, Margaret J; Jessel, Rebecca H; Flaumenhaft, Robert; Nachtigall, Richard; Yoles, Israel; Naftolin, Frederick; Nachtigall, Lila E. The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women. Menopause. 2011 Mar;18(3):285-288 (129318)

Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women
Flaumenhaft, Robert; Nachtigall, Margaret; Lowenstein, Joanna; Nachtigall, Lisa; Nachtigall, Richard; Nachtigall, Lila. Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women. Menopause. 2009 Mar-Apr;16(2):407-412 (129000)